Imagen de Portada

D8.2 Application of IDMP in Drug Labelling and Drug Information, in Clinical Decision Support and in Quality Assurance of Clinical Data

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	UNICOM Consortium
Formato:	Recurso digital
Publicado:	Zenodo 2024
Materias:	IDMP Drug Labelling Clinical Decision Support Quality Assurance of Clinical Data
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Quality of drug information for healthcare professionals: The ARCA acronym
por: Fernando FERNANDEZ-LLIMOS
Publicado: (2015)

D5.1 Business requirements for the adoption of IDMP in eHealth Services, V1
por: UNICOM Consortium
Publicado: (2021)

How Does AI Support Multidisciplinary Team Decisions?
por: Rasit Dinc
Publicado: (2015)

What Are the Alert Fatigue Concerns with Clinical AI?
por: Rasit Dinc
Publicado: (2017)

Replication Data and Code for "Responsible AI in Clinical Decision Support Systems
por: Asemi, Asefeh, et al.
Publicado: (2026)

Application of Artificial Intelligence and Machine Learning in Quality Assurance
por: Momin Anam Rafik*, Chavan Shraddha Mitthu, Dr. Datkhile Sachin Vitthal, Dr. Lokhande Rahul Prakash
Publicado: (2025)

Good Manufacturing Practices (GMP): Building Strong Quality Assurance Systems for Compliance
por: Supreme Trainer
Publicado: (2026)

Big Data Analytics in Intensive Care Units: challenges and applicability in an Argentinian Hospital
por: Javier Balladini
Publicado: (2015)

EXPLAINABLE AI-DRIVEN CLINICAL DECISION SUPPORT SYSTEMS IN PRECISION ONCOLOGY: INTERPRETABLE MODELS FOR MULTIMODAL CANCER CARE
por: Ohmini Krishnamurthy Rajendran
Publicado: (2026)

Oliceridine: Progress in Clinical Research on a New Analgesic Drug
por: Ruixue Li
Publicado: (2025)

The Implementation of AI in Clinical Decision Support System: Effects on Patient Outcomes and Operational Costs
por: Veernapu, Kiran
Publicado: (2023)

Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach
por: Michiel de Vries, et al.
Publicado: (2024)

Leveraging the Software Quality Assurance as a Service (SQAaaS) platform to adopt and get recognition for quality practices in software development.
por: Pablo Orviz, et al.
Publicado: (2023)

The Seamless Integration of Wearables with EHR Systems: An AI-Driven Path to Predictive Healthcare
por: www.rasitdinc.com
Publicado: (2025)

Can I Access AI Radiology Reports? Navigating Patient Rights in the Age of Digital Health
por: www.rasitdinc.com
Publicado: (2023)

How AI Navigates the Ethical Minefield of Medical Conflicts of Interest
por: www.rasitdinc.com
Publicado: (2021)

The Work Behind the First Dose: How Early Clinical Studies Shape the Course of Drug Development
por: Amalia M. Issa
Publicado: (2026)

Quality Assessment Parameters for Student Support at Higher Education Institutions
por: Sajiene, Laima, et al.
Publicado: (2012)

Quality Assurance Frameworks Comparisons in HEIs of Pakistan and China
por: Fatima, Urooj, et al.
Publicado: (2020)

Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study
por: Ramesh Boinpally, et al.
Publicado: (2024)

Impact on process results of clinical decision support systems (CDSSs) applied to medication use: overview of systematic reviews
por: Wálleri C. Reis
Publicado: (2017)

Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
por: Shichang Miao, et al.
Publicado: (2024)

An overview of upcoming changes in pregnancy and lactation labeling information
por: Juan F. MOSLEY II
Publicado: (2015)

Guessability of U.S. pharmaceutical pictograms in Iranian prospective users
por: Mahnaz Saremi
Publicado: (2020)

Patient knowledge of medicines dispensed from Ghanaian community pharmacies
por: Afia F. MARFO
Publicado: (2013)

Lack of Pharmacokinetic Drug–Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs
por: Kelong Han, et al.
Publicado: (2025)

Concentration–QTc Modeling to Support Clinical Development of Fezolinetant
por: Jace C. Nielsen, et al.
Publicado: (2025)

Physiologically Based Pharmacokinetic Modeling to Evaluate Drug‐Drug Interactions of Tacrolimus With Ritonavir, a CYP3A Irreversible Inhibitor: Applications for Dosing Optimization in Transplant Patients
por: Yanjun Jiang, et al.
Publicado: (2025)

Can AI Reduce Unnecessary Medical Testing?
por: Rasit Dinc
Publicado: (2016)

Can AI Improve Outcomes in Critical Care Settings?
por: Rasit Dinc
Publicado: (2018)

Inclusion of salt form on prescription medication labeling as a source of patient confusion: a pilot study
por: Dana J. MCDOUGALL
Publicado: (2016)

Phase 1 Studies to Assess Inhaled Seralutinib as a Perpetrator or a Victim of Drug‐Drug Interactions in Healthy Participants
por: Jianke Li, et al.
Publicado: (2024)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Whitney L. Gustafson
Publicado: (2019)

Attitudes of consumers and healthcare professionals towards the patient package inserts - a study in Palestine
por: Rowa' AL-RAMAHI
Publicado: (2012)

Patients’ views on electronic patient information leaflets
por: Tora HAMMAR
Publicado: (2016)

Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine
por: Hyung Soon Lim, et al.
Publicado: (2024)

A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy
por: Randolph P. Matthews, et al.
Publicado: (2024)

A Drug‐Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2‐ and MATE1‐Mediated Transport of Metformin in Healthy Participants
por: Rajinder Bhardwaj, et al.
Publicado: (2024)

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants
por: Matthias Hoch, et al.
Publicado: (2025)

Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P–Glycoprotein Inhibition
por: Hongxia Jia, et al.
Publicado: (2025)